• Skip to content
  • Skip to search

  • Behind the Science magazine
  • Company
    • Company
    • Purpose, strategy and culture
    • GSK at a glance
    • History and heritage
    • Board of Directors and Executive Committee
    • Board information
    • Governance
      • Governance
      • Committees
      • Shareholders
      • Sarbanes-Oxley Act 2002
      • Compliance
    • Policy positions
    • Codes, standards and reports
  • Innovation
    • Innovation
    • Our leading scientists
      • Our leading scientists
      • Dr Tony Wood
      • Dr Sabine Luik
      • Dr Hesham Ahmed Abdullah
      • Dr Kaivan Khavandi
      • Dr Christopher Austin
      • Charlotte Allerton
      • Dr Sanjay Gurunathan
    • Research and development approach
    • Pipeline
    • Therapeutic areas
      • Therapeutic areas
      • Respiratory, immunology and inflammation
      • Oncology
      • HIV
      • Infectious diseases
    • Tech
      • Tech
      • Post-quantum cryptography
    • Clinical trials at GSK
      • Clinical trials at GSK
      • Provision of unapproved medicines for unmet medical needs
      • Data transparency
      • Representative clinical studies
    • Partnering with GSK
      • Partnering with GSK
      • Supported studies
    • R&D locations
      • R&D locations
      • Flagship R&D centre in Cambridge, UK
  • Products
    • Products
    • Product areas
    • Products A-Z
  • Responsibility
    • Responsibility
    • Access
    • Global health and health security
      • Global health and health security
      • Global health
      • Health security
      • Using our science for global health
      • Improving access to healthcare
      • Africa Open Lab
    • Environment
      • Environment
      • Climate
      • Freshwater
      • Land
      • Oceans
      • Materials and waste
      • Health system sustainability
    • Inclusion
    • Ethical standards
      • Ethical standards
      • Working with third parties
      • Public policy and patient advocacy
      • Human rights
      • Use of animals
      • Engaging with healthcare professionals
    • Product governance
    • Grants and donations
    • Charitable investments
    • Responsibility reports
      • Responsibility reports
      • Reports archive
  • Investors
    • Investors
    • Why invest in GSK?
    • Quarterly results
    • Financial reports
      • Financial reports
      • Annual Report 2025
      • Corporate reports archive
    • Responsible business
    • Speeches and presentations
    • Science publications
    • Events calendar
    • Dividend and share price
      • Dividend and share price
      • GSK share price
      • Share price calculators (GBp/USD)
      • Dividend calculators (GBp/USD)
      • Dividend calendar
    • Analyst consensus
    • Stock exchange announcements
      • Stock exchange announcements
      • London (RNS)
      • London (RNS) inside information
      • New York (SEC)
      • Sign up for announcements
    • Shareholder information
      • Shareholder information
      • Manage your shares
      • Annual General Meeting
      • General Meeting
      • Annual Governance Meeting
      • Corporate sponsored nominee service
      • Our ADR programme
      • Asset reunification - Georgeson
      • Share scam alert
      • Privacy notice for ordinary shareholders
      • FAQs
    • Corporate actions
      • Corporate actions
      • Consumer Healthcare Demerger
      • Consumer Healthcare Joint Venture
      • Agreement to acquire TESARO
    • Debt investors
    • Investor contacts
  • Media
    • Media
    • Press releases
    • Media contacts
    • Media statements
    • Media library
    • Our social media
    • Podcasts
    • RSS feeds
  • Careers
    • Careers
    • Search jobs
    • Featured careers
      • Featured careers
      • A career in data
    • Life at GSK
    • Outstanding people
      • Outstanding people
      • Great place to work
      • Meet our veterans
      • Working together
      • My GSK story
      • Innovating together
    • Experienced professionals
      • Experienced professionals
      • Business operations
      • Engineering at GSK
      • Global supply chain
      • Sales and marketing
      • Research and development
        • Research and development
        • Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)
        • Genomic sciences
      • Technology
    • Early careers
      • Early careers
      • Application process
      • Apprentice programmes
      • Internships and placements
      • Graduate programme
        • Graduate programme
        • Business operations
        • Engineering
        • Manufacturing & supply
        • Commercial
        • Research & development
        • Manufacturing sciences & technology
      • Post graduate opportunities
      • Frequently asked questions
    • Veterans
    • Our global and regional hubs
    • How we hire
      • How we hire
      • Fraudulent internet recruitment activities
      • Frequently asked questions
  • Dark mode

    Switch to dark mode to head towards a more sustainable world together. More info

  • Healthcare professionals Healthcare professionals
  • Contact us Contact us
GSK Homepage
Change locationMenu

  • Global
  • Change location
  • Dark mode

    Switch to dark mode to head towards a more sustainable world together. More info

  • Healthcare professionals Healthcare professionals
  • Contact us Contact us
GSK Homepage
  • Behind the Science magazine
  • Company
  • Innovation
  • Products
  • Responsibility
  • Investors
  • Media
  • Careers
  1. Home
  2. Search

Search

Filters

Format

219 results for "antiviral"

  • PDF - 780.9KBMedia
    Q1 2025 results announcement

    Q1 2025 results announcement

    First published: 30 April 2025

  • PDF - 1.6MBMedia
    Corporate Responsibility Report 2007

    Corporate Responsibility Report 2007

    First published: 17 March 2025

  • PDF - 1.6MBMedia
    Cr Report 2007

    Cr Report 2007

    First published: 01 June 2022

  • PDF - 4.4MBMedia
    Q2 2026 results and accelerate growth slides

    Q2 2026 results and accelerate growth slides

    First published: 28 July 2026

  • PDF - 804.7KBMedia
    Q3 2023 results announcement

    Q3 2023 results announcement

    First published: 26 March 2025

  • PDF - 3.0MBMedia
    Corporate Responsibility Report 2005

    Corporate Responsibility Report 2005

    First published: 17 March 2025

  • PDF - 2.4MBMedia
    Corporate Responsibility Report 2010

    Corporate Responsibility Report 2010

    First published: 17 March 2025

  • PDF - 2.4MBMedia
    Cr Report 2010

    Cr Report 2010

    First published: 01 June 2022

  • PDF - 3.0MBMedia
    Cr Report 2005 (2)

    Cr Report 2005 (2)

    First published: 01 June 2022

  • PDF - 13.1MBMedia
    Strategic report 2025

    Strategic report 2025

    First published: 05 March 2026

  1. previous
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. next
Gsk Logo

This is our global website, intended for visitors seeking information on GSK's worldwide business.  Our market sites can be reached by visiting our location selector.  

 

© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

GSK plc. Registered in England and Wales No. 3888792.

Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG

> Modern Slavery Act Statement 2025 (PDF - 187.7KB)

GSK websites
  • Locations selector
  • Social media directory
  • GSKPro for healthcare professionals
  • GSK study register
  • Supplier website
  • ViiV Healthcare
Quick links
  • Behind the Science magazine
  • Company
  • Innovation
  • Products
  • Responsibility
  • Investors
  • Media
  • Careers
Get in touch
  • Contact us
  • Partnerships
  • Report a possible side effect
  • GSK Speak up
Follow us on:
  • Accessibility
  • Digital sustainability
  • Terms of use
  • Cookie policy
  • Privacy notice
  • Sitemap